Epithelial lung, pancreatic, colorectal, head and neck, and medullary thyroid cancer all have a subset of patients whose cancers are driven by dysregulation of epidermal growth factor (EGF) secretion and/or overexpression/mutation of epidermal growth factor receptor (EGFR) [67]. Here, EGFR is linked to cancer.